FuMDiab | Marjorie Foundation for Diabetes Research

Why are we called Marjorie Foundation?

Insulin was discovered in 1921 by Frederick Banting and Charles Best, in John MacLeod’s lab at the University of Toronto. Both, achieved an extract of pancreas that, on having been administered to dogs subjected to experimental diabetes, was reducing or blunting the presence of glucose in urine. Briefly, with this finding they had discovered insulin, and Banting and MacLeod were awarded the Nobel Prize in Medicine in 1923.

These pancreatic extract administration experiments were conducted in about 10 experimental diabetic dogs. In one of them, named Marjorie, the pancreatic extract held him alive for about 70 days, approximately.

With the purpose of thanking and paying tribute to Marjorie and to all the other dogs that with their sacrifice helped the discovery of insulin, we decided to call the foundation as:
MARJORIE FOUNDATION FOR DIABETES RESEARCH

About us The "Foundation Marjorie for Diabetes Research" (resolution I.G.J. No. 0001915) was founded in 2018 by a group of researchers, health professionals, and citizens committed to the finding of solutions for diabetic patients.

Founder member and President

Biochemist graduated from the Faculty of Exact Sciences and Doctor (Ph.D) in Biochemical Sciences of the National University of La Plata, Argentina. He has completed postdoctoral studies at the University of Manchester (UK), Cedars Sinai Medical Center (UCLA, USA) and the University of Pittsburgh (USA). He is a member of the Scientific and Technological Researcher Career of CONICET (Argentina) and leads the Laboratory of Immuno-Endocrinology, Diabetes and Metabolism at the Instituto de Investigaciones en Medicina Traslacional (IIMT), a research institute dependent of the Faculty of Biomedical Sciences/ Austral University and CONICET.

He is a Visiting Researcher at the Laboratory for Immuno-endocrinology, Department of Biomedical Sciences, University of Copenhagen, Denmark. He is Professor of Biochemistry I and II at the Faculty of Biomedical Sciences, Austral University. He is a member of the Argentine Diabetes Society.

Founder member and Vice-President

Dentist graduated at the Faculty of Dentistry (FO) and Magister in Periodontology at the University of Buenos Aires. She is an authorized lecturer at the Teaching Career (UBA) and an Adjunct Professor of the Chair of periodontics of the Faculty of Dentistry. She is a member of the Committee on genetics, immunology and prevention of diabetes in the Argentine Society of Diabetes.

Founder member and Treasurer

Biologist graduated from the Faculty of Exact and Natural Sciences (FCEyN) and PhD in Biological Sciences from the University of Buenos Aires (UBA). She is an adjunct researcher of the National Scientific and Technical Research Council (CONICET). She conducted research at the Laboratory of Immuno-Endocrinology, Diabetes and Metabolism in the Instituto de Investigaciones en Medicina Traslacional (IIMT), a research institute dependent of the Faculty of Biomedical Sciences/Austral University and CONICET.

She is a lecturer at Biochemistry I and II at the Faculty of Biomedical Sciences, Austral University and at FCEyN-UBA. She is a member of the Argentine Society of Diabetes. She has published numerous papers in the fields of endocrinology, immunology and diabetes.

Member of FuMDiab

Medical doctor (MD) graduated at the Faculty of Medicine (FMed) and Nutrition Specialist of the University of Buenos Aires (UBA). Diabetologist (Graduated at the School of the Argentine Diabetes Society), Master in Diabetes (USAL), Specialist in Internal Medicine (Argentine Society of Internal Medicine, Argentine Medical Association). She is an Authorized Teacher in Internal Medicine (FMed-UBA), Associate Teacher in Nutrition (UBA) and teacher in medicine (UNLaM).

Member of the Argentine Diabetes Society and the Argentine Nutrition Society.

She was Head of the Nutrition-Diabetes Section, National Hospital Prof. Alejandro Posadas (Argentina).

Board certified specialist in internal medicine, endocrinology and diabetology.; March 15th, 2019

Director of Laboratory for Immuno-endocrinology, Department of Biomedical Sciences, University of Copenhagen, Denmark The number of people with Diabetes is expected to rise worldwide around 522 million by 2030 and Argentina does not escape this increase in the prevalence of diabetes. Therefore, in my opinion it is great news for Argentina that Fundación Marjorie para la Investigación en Diabetes (FuMDiab) is now on the road to help promote diabetes research!

I am delighted to provide my enthusiastic support to FuMDiab led by Prof. Marcelo Perone, PhD. I have known Prof. Perone for several years and have followed his important scientific work closely. We have been collaborating actively for the past 4-5 years, primed by his stays here as visiting professor supported by grants from Novo Nordisk Argentina and the Lundbeck Foundation, Denmark. This collaboration so far has resulted in two papers, one published in the leading journal Diabetes. Prof. Perone is adjunct foreign professor at the Department of Biomedical Sciences, University of Copenhagen, Denmark, and as such we continue with his group close collaborative work on diabetes research.

Emeritus Professor of Physiology and Physiopathology at the Medical Faculty of the Philipps-Marburg University, Germany.; 19 de mayo de 2019

I would like to congratulate FuMDiab leaders on their commitment to supporting scientific research with the aim of deepening knowledge in diabetes. I see with great enthusiasm that Argentine non-profit organizations are committed to scientific research. In this sense, it is very valuable that FuMDiab intends to replicate the actions of various research support organizations existing in Europe and North America that have been in place for a long time.

Finally, I would like to stress my full support for the initiatives put forward by FuMDiab over the next few years.